Liquid Biopsy: A New Tool for Overcoming CDKi Resistance Mechanisms in Luminal Metastatic Breast Cancer

Breast cancer (BC) is the most common cancer diagnosed in women worldwide. Approximately 70% of BC patients have the luminal subtype, which expresses hormone receptors (HR+). Adjuvant endocrine treatments are the standard of care for HR+/HER2− BC patients. Over time, approximately 30% of those patie...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Conde, Miriam, Yañez-Gómez, Celso, López-López, Rafael, Costa, Clotilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153557/
https://www.ncbi.nlm.nih.gov/pubmed/34068388
http://dx.doi.org/10.3390/jpm11050407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153557/
https://www.ncbi.nlm.nih.gov/pubmed/34068388
http://dx.doi.org/10.3390/jpm11050407

Ejemplares similares